Home > Urology > EAU 2019 > Prostate Cancer > Prostate cancer: What to expect the next 12 months

Prostate cancer: What to expect the next 12 months


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Conference
EAU 2019
Trial
STAMPEDE, ENZAMET
On Friday 15 March, the European School of Oncology held their 6th Prostate Cancer Observatory: innovations and care in the next 12 months, as a kick-off session for EAU19. The point of this session is to feature forecasts in prostate cancer management from multidisciplinary viewpoints on what to expect in the coming year. The room was packed with hundreds of people, and just entering the room took over 20 minutes, reflective of the attractive format this high-level session has adopted to provide the audience with updated and unbiased "sneak peaks" on the near-future expected outcomes for prostate cancer. Below is the top-12 of what's on the horizon: This last year brought major changes with respect to the implementation of MRI prior to biopsy, and the guidelines have been changed. The coming year will bring incremental and important refinements to the use of MRI (which underestimates tumour volume by 2.7x). In focal therapy, t...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on